Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, July 21, 2026

Snapshot: Jul 21, 2026 · 6:00 PM 100 stocks analyzed

Down Day

Tue, Jul 21, 2026 Divergent High

Broad selloff in large caps masked a wild bifurcation as small caps soared and mega-cap tech tanked, with Financial Services hemorrhaging 36% of losers while extreme dispersion …

55% S&P 500 fell 0.46% and NASDAQ Composite sank 1.03%, but the divergence was the story: Russell 2000 surged 0.76%, Russell 2500 gained 1.17%, and mid-caps rose 0.18%, signaling a sharp rotation out of mega-cap tech into beaten-down small caps while large-cap financials bore the brunt of selling pressure.
30% Extreme dispersion with 50 top gainers averaging +49% and 50 top losers averaging -22% created a stock-pickers' battlefield; CPHI exploded 790%, UTZ jumped 89% on Intersnack acquisition news, while LBGJ crashed 73% and ZYBT plunged 64% with no disclosed catalysts, reflecting frenzied individual-stock volatility across the tape.
15% Financial Services dominated losers at 36% of the losing list led by Columbia Financial's 55% collapse on merger dilution, while a 5-name debutant wave in gainers—including leveraged biotech and semiconductor ETFs—highlighted micro-cap and leverage-fueled trading activity despite VIX rising 8.8% on the day's chaos.

Financial Services drove 36% of losers 5 names returned after long absences TGHL · 3-day losers streak UTZ — first appearance HYNX — first appearance

Market Regime

Tue, Jul 21, 2026 Neutral conf: low macro · prototype

Neutral −100 … +100 · + tailwind / − headwind

VIX17.1 Drawdown-1.3% Held11d · established SinceJul 7

Top drivers: S&P drawdown (60d) ▲ Small-cap leadership ▼ S&P 20d return ▲

processId: history-market-regime

Market Indexes

Tue, Jul 21, 2026 13

S&P 500

7,509.20

−34.39

-0.46%

Dow Jones

52,224.64

−283.63

-0.54%

NASDAQ Composite

25,837.21

−269.80

-1.03%

NASDAQ 100

29,155.18

−431.11

-1.46%

DJ US Total Market

74,399.05

−334.21

-0.45%

Russell 1000

4,087.99

−20.30

-0.49%

S&P MidCap 400

3,784.23

+6.97

+0.18%

Russell 2000

2,987.40

+22.64

+0.76%

Russell 2500

1,263.81

+14.56

+1.17%

Russell 3000

4,271.21

−18.92

-0.44%

Nasdaq Financial-100

7,451.97

−5.11

-0.07%

NIFTY 50

24,187.70

+109.20

+0.45%

VIX

17.05

+1.38

+8.81%

Biggest Gainers

Tue, Jul 21, 2026 50

CPHI

China Pharma Holdings, Inc.Healthcare

$8.10+$7.19

+790.1%

AMEX · Mkt cap $44 M

China Pharma Holdings announced it is aware of unusual market activity in its stock but the full statement was truncated in the provided headline, making the specific catalyst unclear. A 790% single-day gain suggests either a major corporate action, acquisition, or short squeeze rather than norma…

The only news provided is a company statement acknowledging unusual market activity, but the actual content of that announcement is cut off mid-sentence. This leaves the specific driver unknown. China Pharma is a small-cap specialty pharmaceutical company listed on NYSE American, a venue historically home to lower-liquidity stocks that can experience outsized moves on limited volume. Given the magnitude of the move, plausible explanations include a merger or acquisition announcement, major licensing deal, clinical trial success, debt restructuring, or technical short squeeze. Without the complete statement, attributing this move to any particular cause would be speculation. The company's own acknowledgment of unusual activity suggests management recognizes something material has occurred, but investors lack sufficient detail to assess legitimacy or fundamental merit of the move.

OMH

Ohmyhome LimitedReal Estate

$0.81+$0.56

+222.7%

NASDAQ · Mkt cap $7.7 M

No news headlines were found in the last 48 hours, so the +223% gain on OMH cannot be traced to a disclosed catalyst. The jump may reflect technical trading, an undisclosed announcement, or speculative interest in a low-priced stock.

OMH experienced an extraordinary single-day surge of over 222% with zero supporting news in the available feeds. This is a critical disconnect. For a micro-cap or penny stock trading at $0.81, such moves are often driven by factors other than mainstream financial news: technical breakouts from extended consolidation, short squeeze activity, social media-driven retail interest, or undisclosed company announcements not yet picked up by the RSS feeds sampled. It is also possible that material news exists but has not yet propagated to the Yahoo Finance RSS source, or that the move reflects a corporate action (reverse split, for example) that doesn't always register as a headline. Without either corroborating news or knowledge of OMH's specific corporate structure and shareholder composition, any explanation remains speculative.

SLGB

Smart Logistics Global Limited Ordinary SharesIndustrials

$0.98+$0.47

+92.5%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 92.48% surge in SLGB stock cannot be attributed to a disclosed catalyst; the move likely reflects technical trading, retail momentum, or undisclosed company news.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to anchor the explanation in a specific event. SLGB is a micro-cap stock trading near $1, which typically exhibits high volatility and is susceptible to technical rebounds, short-covering, or retail trading momentum, especially after sharp prior declines. Stocks in this price range can also be subject to rumor-driven moves on social media or discussion boards that do not surface as formal news headlines. Another possibility is that a material announcement (earnings, corporate action, or business update) was released but has not yet been indexed by the RSS feed or Yahoo Finance at the time of this snapshot. Without access to the company's investor relations page or press releases directly, we cannot rule out that a genuine catalyst exists but simply was not captured in the provided headlines.

UTZ

Utz Brands, Inc.Consumer Defensive

$14.06+$6.61

+88.7%

NYSE · Mkt cap $2.0 B

Utz Brands surged 88.72% on announcement that German snack maker Intersnack agreed to acquire the company for $2.9 billion in an all-cash take-private deal at $14.25 per share, representing a 91% premium to prior trading levels.

The headlines establish a clear M&A catalyst. Intersnack Group announced on July 21, 2026 that it would acquire Utz Brands in a take-private transaction valued at approximately $2.9 billion including debt. The offer price of $14.25 per share represents a substantial premium to the stock's pre-announcement trading price, which explains the dramatic intraday surge to $14.06 to $14.10 observed across multiple news reports. All reported headlines focus exclusively on this acquisition announcement with consistent messaging across financial outlets, indicating this was the dominant market event for the stock on that date. The timing of the news release in mid-afternoon (15:46 UTC according to the earliest report) aligns with the heavy trading volume and sharp price movement noted in the reporting.

JZXN

Jiuzi Holdings, Inc.Consumer Cyclical

$1.93+$0.78

+67.8%

NASDAQ · Mkt cap $687 K

No news headlines were found in the last 48 hours, so the 67.83% gain cannot be directly attributed to a disclosed corporate event or market announcement.

Without any recent news coverage, the sharp single-day jump in JZXN stock cannot be traced to a specific earnings report, contract win, regulatory approval, or strategic announcement. For a micro-cap or thinly traded stock like this, such moves are typically driven by one of several categories: a press release or announcement that has not yet been indexed by the RSS feed, technical factors such as short covering or options-related gamma hedging, retail trading momentum, or rumors circulating on social media or trading forums. Given that JZXN ranked number five in daily gainers, it suggests either material news is pending confirmation or liquidity constraints in a lower-volume security amplified even modest buying interest. Without substantive information about the company's business, recent financial performance, or market structure, it is not possible to determine which hypothesis applies.

NIPG

NIP Group Inc.Communication Services

$7.50+$2.78

+58.9%

NASDAQ · Mkt cap $80 M

No news headlines were found in the last 48 hours, so the 58.90% gain likely reflects a delayed news release, technical rebound, or event not yet picked up by major news feeds.

The absence of any recent headlines despite a substantial single-day gain of nearly 59 percent makes it difficult to pinpoint a specific catalyst with confidence. This type of move in a lower-priced stock could stem from several common scenarios: a delayed earnings announcement or guidance revision that hasn't yet been syndicated to major news sources, a corporate action such as a stock split or dividend announcement, short covering or technical momentum following oversold conditions, or an unconfirmed rumor circulating in retail trading channels. Without access to company filings, press releases direct from the issuer, or corroborating news sources beyond the Yahoo Finance RSS feed provided, the true cause remains unclear. The rank as the sixth biggest gainer suggests broad market awareness, but the lack of news coverage is unusual for a move of this magnitude.

DFNS

T3 Defense Inc.Industrials

$6.57+$2.31

+54.2%

NASDAQ · Mkt cap $27 M

T3 Defense subsidiary ITS announced delivery of an advanced composite materials production line to a major industrial manufacturer on July 20, which likely drove the 54% stock surge by signaling successful commercialization of defense-grade technology into high-volume industrial markets.

The headline establishes a concrete business development: ITS Designs, a T3 Defense subsidiary, has delivered a custom composite materials production line incorporating defense-proven fiberglass technology to an unspecified leading building materials manufacturer. This represents tangible revenue-generating activity and demonstrates technology transfer from the defense sector to industrial scale manufacturing. The timing of the announcement on July 20 and the stock's +54% move on July 21 shows strong market enthusiasm for this milestone. However, the news release lacks specific financial details such as contract value, timing of revenue recognition, or margin profile, which limits full assessment of the move's fundamental justification. The market appears to be pricing in either significant near-term revenue potential, strategic validation of the business model, or broader confidence in management's ability to execute commercialization. Without additional context on company guidance or analyst expectations, it is difficult to determine whether this move represents rational repricing or initial market enthusiasm that may moderate.

VIVK

Vivakor, Inc.Energy

$2.58+$0.85

+49.1%

NASDAQ · Mkt cap $864 K

Vivakor announced expansion of its crude oil marketing platform to over $700 million in annualized commercial activity with four new recurring transactions, driving the 49% gain.

On July 21st, Vivakor disclosed that its physical crude oil marketing platform had expanded beyond $700 million in annualized commercial activity through four new recurring commercial transactions. These deals increase marketed volumes to 300,000 barrels per month (3.6 million barrels annually) and are expected to generate approximately $289 million in annualized commercial activity based on current market conditions. For a small-cap energy marketing firm, this represents material business expansion with concrete volume and revenue metrics. The announcement directly addresses the company's core business model and demonstrates growth in its commercial footprint. The magnitude of the gain (49%) is consistent with a positive operational catalyst for a micro or small-cap stock trading at this price level, where percentage moves can be volatile but are often anchored to specific business developments rather than pure momentum.

NBIL

GraniteShares 2x Long NBIS Daily ETF

$30.72+$8.38

+37.5%

NASDAQ

No news headlines were found in the last 48 hours, but NBIL is a 2x leveraged long ETF on the Nasdaq Biotechnology Index (NBIS), so a 37.51% gain likely reflects a sharp rally in biotech stocks themselves, amplified by the fund's 2x daily leverage structure.

The absence of company-specific or market-wide news in the provided headlines does not explain the move directly, but NBIL's structure offers a clear explanation pathway. NBIL is designed to deliver twice the daily return of the NBIS index, which tracks Nasdaq-listed biotechnology companies. A 37.51% jump in NBIL would correspond to approximately an 18.75% single-day gain in the underlying NBIS index, a magnitude plausible for a sector-wide rally driven by positive biotech sentiment, favorable regulatory signals, or broad risk-on trading. The absence of a specific headline does not mean no catalyst occurred; it may reflect either a delayed indexing of news into the RSS feed, a sector-wide or market-structure event not captured by individual company announcements, or intraday momentum. Leveraged ETFs also reset daily, so prior-day moves plus daily performance could accumulate.

NBIG

Leverage Shares 2x Long NBIS Daily ETF

$21.26+$5.75

+37.1%

NASDAQ

No news headlines were found in the last 48 hours, but NBIG is a 2x leveraged long ETF tracking NBIS, so a 37% surge likely reflects a sharp rally in the underlying index amplified by the fund's 2x daily leverage mechanism.

NBIG is a leveraged ETF product designed to deliver twice the daily performance of its underlying index NBIS. With no recent news available, the 37% gain most likely stems from a significant rally in NBIS itself, which the 2x leverage multiplies mechanically. Leveraged ETFs respond to intraday moves in their benchmark; a ~18-19% jump in the underlying would produce roughly this magnitude of move in the fund. The absence of headlines does not rule out a catalyst—it may reflect breaking news, earnings, sector rotation, or technical strength in the underlying index that simply has not yet appeared in the Yahoo Finance RSS feed, or the move could be driven by technical factors, short covering, or options-related positioning. Without visibility into NBIS performance or broader market context, we cannot isolate the specific cause.

GREE

Greenidge Generation Holdings Inc.Financial Services

$2.91+$0.78

+36.6%

NASDAQ · Mkt cap $39 M

Greenidge Generation announced a $39.4 million capital raise, corporate rebrand to Vulcan Infrastructure and Power, and strategic pivot from bitcoin mining to AI/HPC data center infrastructure, which drove the 36.62% gain on investor enthusiasm for the new business direction.

The company's announcement of a substantial capital raise paired with a strategic business transformation appears to be the primary driver of the sharp one-day gain. The shift away from cryptocurrency mining toward powering AI and high-performance computing infrastructure represents a pivot into a sector with stronger institutional investor demand. The $39.4 million raise will be used primarily to redeem senior debt, improving the balance sheet and reducing leverage. Rebranding from Greenidge to Vulcan Infrastructure and Power signals management's commitment to the new identity and presumably cleaner separation from the legacy bitcoin mining business. The combination of fresh capital, balance sheet improvement, and repositioning into an attractive growth narrative likely resonated with the market, particularly for a stock that may have been depressed or out of favor during the earlier cryptocurrency downturn.

KIDZ

KIDZ AI Inc.Consumer Defensive

$0.56+$0.15

+35.9%

NBRGR

Newbridge Acquisition Limited Rights 2026-21.10.27 For Shares

$0.25+$0.06

+31.5%

NASDAQ

No news headlines were found in the last 48 hours, so the 31.53% jump in this SPAC rights offering is unexplained by reported events; the move likely reflects either technical trading activity, delayed news, or market-specific activity in the rights instrument itself.

Newbridge Acquisition Limited Rights are a special purpose acquisition company rights offering with an expiration date of October 27, 2026. No news headlines appear in the last 48 hours to explain the sharp 31.53% gain. Rights offerings are thinly traded instruments prone to volatility and can move on factors unrelated to fundamental news, including changes in the underlying common stock price, shifts in merger probability or SPAC deal timing, options-related hedging activity, or simple technical momentum in a low-liquidity security. Without accompanying news, it is impossible to identify a specific catalyst. The move could reflect a delayed announcement not yet captured in the RSS feed, renewed interest in the parent SPAC due to deal progress, or pure technical/retail trading in a volatile micro-cap instrument.

GRML

Greenland Mines Ltd.Basic Materials

$0.24+$0.06

+29.9%

NASDAQ · Mkt cap $31 M

Greenland Mines announced a 12+ million share issuance to AnorTech valued at ~$3.5 million, likely positioning the company in rare earths and advanced materials with lunar/space applications, driving a 30% single-day rally.

The headline reveals a share exchange transaction completed on July 20 where GRML issued over 12 million common shares to AnorTech, a company developing proprietary technology around anorthosite—a mineral abundant in Greenland and on the moon. The article framing ties together rare earths, advanced materials, and space applications, suggesting this deal may represent a significant strategic pivot or partnership into higher-growth sectors. For a micro-cap stock trading at $0.24, any headline indicating new strategic partnerships, access to rare earth assets, or space-related technology can trigger substantial percentage gains, especially if the market views the deal as dilutive but strategically valuable. The incomplete headline prevents full assessment of deal terms and AnorTech's technology specifics, but the naming of lunar applications appears designed to appeal to emerging space economy interest.

WGRX

Wellgistics Health, Inc.Healthcare

$3.52+$0.81

+29.9%

NASDAQ · Mkt cap $157 M

Wellgistics Health officially rebranded to DataMeds AI on July 21, a corporate name change that likely triggered renewed investor interest in the company's AI-focused pharmacy platform strategy, driving the 29.89% gain.

The headline announces an official corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc., effective on the snapshot date itself. This is a material corporate event that signals a strategic pivot toward emphasizing the company's artificial intelligence capabilities, specifically its EinsteinRx pharmacy dispensing AI platform and PharmacyChain smart contracts technology. Rebranding to highlight AI assets can attract investor attention in a market where AI narratives drive valuations, particularly for healthcare IT companies. The timing of the announcement with the price jump suggests the market views the rebrand positively as a repositioning toward higher-growth AI segments. However, the headline does not disclose financial results, partnership wins, or specific revenue drivers, so the move reflects sentiment around strategic direction rather than fundamental performance metrics.

BEG

Leverage Shares 2x Long BE Daily ETF

$42.57+$9.47

+28.6%

NASDAQ

No news headlines were found in the last 48 hours, but BEG's 28.61% gain is most likely driven by a strong rally in its underlying asset, as this is a 2x leveraged long ETF that amplifies daily moves in the Benchmark Esports index or related holdings.

Yahoo Finance returned no recent news headlines for BEG in the past 48 hours, so the jump cannot be attributed to a company-specific announcement, earnings surprise, or product development. However, BEG is structurally a leveraged daily ETF, meaning it is designed to deliver twice the daily return of its underlying benchmark. A 28.61% gain in BEG would correspond to approximately a 14.3% gain in the underlying index or holdings on the previous trading day. This kind of move in a leveraged ETF is typically explained by a substantial rally in the basket of stocks it tracks—in this case, likely esports-related equities. Without access to the underlying performance data or broader market context for that day, the most probable explanation is a broad sector rally in esports stocks rather than any isolated catalyst specific to BEG itself. Other possibilities include a delayed news announcement not yet reflected in the Yahoo feed or strong technical momentum, but these remain speculative.

MLEC

Moolec Science S.A.Healthcare

$8.45+$1.85

+28.0%

NASDAQ · Mkt cap $5.0 M

No news headlines were found in the last 48 hours for MLEC, so the 28% gain on July 21 likely reflects a delayed market reaction to an older announcement, technical momentum, or an untracked catalyst.

Moolec Science is a biotech/agtech company focused on precision fermentation and genetically modified plants, a sector that can experience sharp moves on clinical updates, partnership announcements, or investor sentiment shifts. The absence of recent headlines in the Yahoo Finance feed does not rule out news from company channels, social media, or specialized biotech news sources published within the window. This stock trades at relatively low absolute price and volume, which makes it susceptible to technical rallies or retail interest spikes that can amplify percentage moves. Without a specific catalyst identified in the provided headlines, the driver remains speculative; it could be a delayed market digestion of an earlier announcement, a technical breakout, a sector rotation into fermentation-based biotech plays, or undisclosed rumors.

AEHR

Aehr Test SystemsTechnology

$98.91+$21.55

+27.9%

NASDAQ · Mkt cap $2.6 B

AEHR was added to Zacks Rank 1 (Strong Buy) list on July 20th, a recognition that likely drove the 27.86% gain as momentum investors responded to the analyst upgrade across multiple publications.

Three separate news items published on July 20th highlight AEHR's addition to the Zacks Rank 1 (Strong Buy) list. Two of these explicitly name AEHR as a momentum stock or strong buy recommendation, and a third article compares AEHR's performance to sector peers, suggesting increased analyst attention. The timing aligns precisely with the stock's 27.86% jump on July 21st. While the headlines do not disclose specific fundamental catalysts like earnings beats, contract wins, or guidance raises, the repeated appearance on analyst ranking lists within a 5-hour window on July 20th represents a material shift in consensus rating that typically attracts momentum-driven trading. For a semiconductor test equipment manufacturer, upgraded analyst sentiment can trigger institutional and algorithmic buying, especially if the stock had previously lagged its peers or faced headwinds.

HYNX

T-REX 2X Long SK Hynix Daily Target ETF

$28.81+$6.23

+27.6%

AMEX

No news headlines were found in the last 48 hours, but HYNX is a 2X leveraged ETF on SK Hynix, so a +27.59% move likely reflects a sharp gain in the underlying semiconductor stock, possibly driven by sector momentum, earnings, or positive chip demand signals.

The absence of recent headlines makes direct attribution impossible. However, HYNX is a daily target leveraged ETF that amplifies the SK Hynix stock price by 2X, meaning a roughly 13-14% move in the underlying SK Hynix stock would produce the observed 27.59% gain (accounting for compounding effects in daily resets). This suggests the driver is either a significant move in SK Hynix itself or in the broader semiconductor sector. Possible catalysts in this category include earnings announcements, positive guidance from memory chip makers, industry supply-demand shifts, or macroeconomic signals that favor semiconductor cyclicals. Without access to SK Hynix-specific news or intraday sector reports, the specific trigger remains unclear, but the gain magnitude is consistent with a fundamental or sentiment shift affecting the chip sector.

SKHU

Proshares Ultra Sk Hynix

$22.87+$4.94

+27.6%

AMEX

No news headlines were found in the last 48 hours, but SKHU is a 3x leveraged inverse ETF on SK Hynix, so a 27.55% gain likely reflects a sharp decline in the underlying stock or semiconductor sector, amplified by the fund's leverage structure.

Zero news items appeared in the Yahoo Finance RSS feed for this security in the past two days. However, SKHU's structure provides a concrete explanation pathway. This is a ProShares Ultra Short SK Hynix ETF with approximately 3x inverse leverage. A 27.55% daily gain in this instrument would typically correspond to a roughly 8-10% single-day decline in SK Hynix stock itself, amplified by the leverage ratio and daily rebalancing mechanics. The catalyst for SK Hynix weakness could stem from sector-wide semiconductor selloff, company-specific news, or macroeconomic factors affecting memory chip demand or valuations. Without headlines in the provided feed, we cannot identify which of these drove today's move, but the magnitude and direction are consistent with the underlying equity moving sharply lower.

SKHL

Direxion Daily SK Hynix Bull 2X ETF

$11.12+$2.36

+26.9%

AMEX

No news headlines were found in the last 48 hours, but SKHL is a 2X leveraged bull ETF on SK Hynix, so a strong gain in the underlying semiconductor stock would be amplified roughly twofold in the fund, making this move consistent with a significant rally in HYH or the broader chip sector.

The absence of news in the provided headlines does not explain the 26.94% jump on its own. However, SKHL is a leveraged inverse-multiplier ETF designed to deliver 2X daily gains from SK Hynix. This structural feature means the fund amplifies moves in its underlying asset. A strong single-day rally in semiconductor stocks or SK Hynix specifically—whether driven by sector momentum, AI-chip demand, earnings optimism, or technical factors—would be magnified to roughly double that move in SKHL. The gain is large but not implausibly so for a 2X leveraged instrument during a strong market day for its sector. Without headline confirmation, the most likely categories of catalyst are sector-wide semiconductor strength, positive chip-demand signals, or a favorable earnings surprise or guidance revision from SK Hynix or peers.

SKUU

GraniteShares 2x Long SK Hynix Daily ETF

$28.58+$6.04

+26.8%

NASDAQ

No news headlines were found in the last 48 hours, but SKUU is a 2x leveraged ETF tracking SK Hynix, so a strong underlying move in the semiconductor sector or SK Hynix stock itself would be amplified roughly twofold in the fund's daily performance.

The absence of any news in the provided headlines makes it impossible to identify a specific catalyst. However, SKUU's structure as a daily leveraged (2x) ETF means its +26.80% move is consistent with an underlying move of roughly +13-14% in SK Hynix or the broader semiconductor complex over the snapshot period. Leveraged ETFs amplify daily percentage moves by their stated multiple, so large single-day gains in this fund typically reflect either a meaningful rally in the underlying asset, sector rotation into semiconductors, geopolitical developments affecting chip supply, or positive guidance from major memory chipmakers. Without access to SK Hynix's stock price action or semiconductor sector news for the relevant dates, we cannot pinpoint which of these categories drove the move.

AMPGZ

Amplitech Group, Inc. Series B Right

$1.00+$0.21

+26.6%

NASDAQ

AmpliTech announced receipt of approximately $21.9 million in Series A rights offering subscriptions on July 20, likely driving the 26.58% gain in the Series B rights security AMPGZ as investor confidence in the company's capital raise improved.

On July 20, 2026, AmpliTech Group disclosed that it received $21.9 million in subscriptions from its Series A Rights Offering, with all Series A rights exercised or expired as of July 18. This announcement demonstrates concrete shareholder participation in the company's capital raise, which typically signals investor confidence and strengthens the company's balance sheet. The timing and structure suggest this positive reception of Series A rights would likely encourage similar participation in the Series B rights offering, the security that moved 26.58% higher. Rights offerings that attract strong subscription levels are viewed favorably by the market as they reduce execution risk and indicate demand for the company's equity. This is a direct capital events catalyst rather than operational or market-driven movement.

NXXT

NextNRG Inc.Utilities

$0.35+$0.07

+25.9%

NASDAQ · Mkt cap $40 M

No news headlines were found in the last 48 hours for NXXT, so the 25.88% gain on July 21st cannot be attributed to a specific announced event; the move likely reflects either a delayed market reaction, technical trading, or unindexed information.

The absence of any Yahoo Finance headlines in the past two days makes it impossible to tie this substantial 25.88% intraday gain to a concrete news event such as earnings, regulatory approval, partnership announcement, or guidance change. NXXT is a micro-cap energy stock trading at $0.35, which typically exhibits high volatility and can be susceptible to retail trading interest, short covering, or technical breakouts that occur without simultaneous press releases. It is also possible that a material announcement was made but has not yet been indexed by the RSS feed, or that the move is purely momentum-driven. Without access to company filings, social media chatter, or real-time news sources beyond the provided headlines, attributing causality remains speculative.

PDC

Perpetuals.com LtdTechnology

$3.99+$0.82

+25.9%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, so the 25.87% gain on PDC cannot be attributed to a specific announced event; the driver remains unclear without additional reporting.

PDC experienced a sharp 25.87% single-day rally to $3.99 with no corresponding news coverage in the Yahoo Finance RSS feed over the prior 48 hours. This disconnect between price action and public information creates several plausible but unconfirmed hypotheses. First, the move could reflect delayed market reaction to an older announcement not captured in the recent news window. Second, small-cap stocks like PDC are often sensitive to technical factors, short covering, or retail trading activity that may not immediately trigger headline coverage. Third, material news may have been released through company channels (press release, investor update, social media) but not yet picked up by major financial news aggregators. Without access to company filings, insider activity, or real-time trading data, attribution remains speculative. The stock's relatively low price point ($3.99) and position as the 25th biggest gainer suggests significant volatility is common for this security.

TERG

Leverage Shares 2X Long TER Daily ETF

$43.40+$8.57

+24.6%

NASDAQ

No headlines were found in the last 48 hours, but TERG is a 2X leveraged long ETF tracking TER, so a ~12% surge in the underlying TER stock would mechanically produce approximately this 24.6% gain in the fund.

The absence of news headlines does not mean the move is unexplained; TERG is a daily 2X leveraged instrument designed to amplify the daily returns of its underlying index or security TER. A roughly 12% move in TER on July 21 would mechanically translate to a ~24% move in TERG, accounting for compounding effects over the day. The underlying cause of the move—whether TER itself experienced a positive earnings surprise, analyst upgrade, sector rotation, technical breakout, or acquisition news—would reside in TER's fundamentals or technicals, not in TERG itself. Without headlines on TERG or TER, we cannot identify the specific catalyst, but the magnitude and direction of TERG's move are entirely consistent with leveraged amplification of a material single-day move in its underlying.

MUU

Direxion Daily MU Bull 2X ETF

$35.14+$6.83

+24.1%

NASDAQ

No news headlines were found in the last 48 hours, but MUU is a 2X leveraged ETF tracking Micron Technology (MU), so a +24.13% gain likely reflects a strong move in the underlying stock driven by positive market sentiment or company-specific catalyst.

The absence of recent news headlines makes it impossible to identify a specific catalyst from published reports. However, MUU is a leveraged inverse tracking instrument designed to amplify daily moves in Micron Technology by approximately 2X. A +24.13% move in MUU would correspond to roughly a +12% move in MU itself, which is substantial for a single day. Such a move in the semiconductor space is typically driven by factors including earnings surprises, positive guidance revisions, sector-wide semiconductor demand signals, geopolitical developments affecting chip supply chains, or major customer wins. Without access to today's MU announcement or market developments, the specific trigger remains unclear, though the size of the move suggests either a significant company announcement, analyst upgrade, or broad semiconductor sector momentum.

BANL

CBL International LimitedEnergy

$5.16+$1.00

+24.0%

NASDAQ · Mkt cap $26 M

No headlines were found in the last 48 hours for BANL, so the 24% gain cannot be tied to a specific disclosed event. The jump likely reflects either delayed market reaction to an earlier announcement, technical trading, or a small-cap catalyst not yet indexed by Yahoo Finance.

The absence of recent news headlines makes it difficult to pinpoint a definitive cause for the 24% single-day gain in BANL stock. For micro-cap and small-cap securities like CBL International Limited, moves of this magnitude can occur from several sources: a delayed market reaction to an announcement made before the 48-hour window, short-covering or retail trading momentum, technical breakouts, or developments not yet picked up by major financial news feeds. Without access to company press releases, SEC filings, or real-time market commentary, it is not possible to establish a concrete link between identifiable news and the price action. The timing of the move relative to any catalyst remains unknown.

MULL

GraniteShares 2x Long MU Daily ETF

$24.45+$4.70

+23.8%

NASDAQ

No news headlines were found in the last 48 hours, but MULL is a 2x leveraged long ETF on Micron Technology (MU), so a 23.8% gain most likely reflects a sharp rally in the underlying semiconductor stock.

The absence of news in the headline feed does not mean no catalyst occurred; rather, the relevant news likely concerns Micron Technology (MU) directly, not the MULL ETF itself. MULL is a daily-reset leveraged product designed to amplify MU's price movements by 2x, so a roughly 12% move in MU would produce the observed 23.8% gain in MULL. This kind of leveraged ETF is primarily responsive to its underlying asset's price action. The catalyst could be sector-wide semiconductor strength, MU-specific technical buying, fund flow events, or breaking news about MU that has not yet propagated to the Yahoo Finance RSS feed captured here. Without visibility into concurrent MU price action or semiconductor sector headlines, we cannot pinpoint the exact cause, but the mechanism is clear: the leveraged structure amplified whatever moved MU today.

FWRD

Forward Air CorporationIndustrials

$16.21+$3.01

+22.8%

NASDAQ · Mkt cap $551 M

Forward Air announced it will retain at least 50% of a $250M customer account representing 10% of annual revenue, reversing prior risk of losing the contract entirely and driving a strong relief rally.

Forward Air faced material risk of losing a major customer account worth approximately $250 million annually, representing roughly 10% of company revenue. The July 21 announcement that the company will retain at least half of this account constitutes a significant de-risking event. The market appears to have been pricing in the possibility of total account loss, so securing 50% represents a material positive outcome relative to worst-case expectations. This type of contract retention or partial recovery in logistics and freight services typically triggers sharp relief rallies when announced, particularly for a company where one customer represents such a large revenue concentration. The 22.8% single-day gain reflects investor relief rather than unexpected upside, suggesting the market had incorporated meaningful loss probability into the prior valuation.

CIFG

Leverage Shares 2X Long CIFR Daily ETF

$10.60+$1.94

+22.4%

NASDAQ

No headlines were reported in the last 48 hours, but CIFG is a 2X leveraged ETF tracking CIFR, so a ~11% move in the underlying would naturally produce approximately a 22% move in this security through mechanical amplification.

The lack of recent news headlines creates ambiguity about what drove the underlying CIFR index or its constituent holdings on this trading day. However, CIFG is a daily leveraged ETF designed to deliver twice the daily return of CIFR. A 22.44% gain in CIFG is mathematically consistent with approximately an 11% gain in CIFR itself. The underlying catalyst could stem from several sources: a significant positive announcement regarding one or more holdings in the CIFR benchmark, broad market movement in the sector CIFR tracks, short-covering, options-related hedging flows, or technical momentum. Without news headlines for context, the most likely structural cause is straightforward: the underlying index moved substantially, and leverage amplified that move as designed.

LPTH

LightPath Technologies, Inc.Technology

$12.66+$2.30

+22.2%

NASDAQ · Mkt cap $605 M

No news headlines were found in the last 48 hours, so the 22% rally cannot be attributed to reported corporate events; the move likely reflects technical trading, sector momentum, or untracked developments.

LightPath Technologies jumped 22% on July 21 with zero news coverage identified in the most recent 48-hour window. This disconnect between a substantial single-day gain and the absence of reported catalysts suggests either a delayed market reaction to older news not captured in the current feed, technical buying or short covering in a thinly traded small-cap stock, sector-wide momentum in optical or photonics plays, or an untracked announcement such as a private placement, insider filing, or social media-driven retail interest. Small-cap industrial optics companies are often subject to outsized intraday swings on modest volume. Without access to real-time order flow, insider transactions, or specialized sector news wires, pinpointing the specific driver is not possible from the evidence at hand.

DYAI

Dyadic International, Inc.Healthcare

$1.47+$0.26

+21.5%

NASDAQ · Mkt cap $30 M

No news headlines were found in the last 48 hours, so the 21.49% gain likely reflects a technical rebound, delayed market reaction to an older announcement, or market rumors not yet captured in the available feeds.

Dyadic International is a small-cap biotech firm with a market capitalization typically under $100 million, making it sensitive to technical moves and retail attention. A 21.49% single-day jump in the absence of fresh news is common for stocks of this size and liquidity profile. The move could reflect several scenarios: a delayed positive reaction to an older press release or earnings report not yet indexed in the 48-hour window, short covering if the stock had been shorted heavily, technical oversold conditions triggering a bounce, or social media or message-board momentum among retail traders. Without contemporaneous headlines, it is impossible to identify a specific catalyst. Biotech stocks this small often experience outsized moves on clinical trial results, partnership announcements, or FDA decisions, but no such event appears in the available data.

RCAX

Daily Target 2X Long RCAT ETF

$3.68+$0.64

+21.1%

NASDAQ

No news headlines were published in the last 48 hours, but RCAX is a 2X leveraged long ETF tracking RCAT, so a strong rally in the underlying index would naturally amplify to a 21% gain in this inverse-ETF product.

The absence of any news in the provided feed makes direct causation impossible to establish. However, RCAX is a daily target 2X long leveraged ETF, which means it is designed to deliver twice the daily return of its underlying index or security. A gain of approximately 10-11% in the underlying RCAT holding would mechanically produce a roughly 21% move in RCAX before accounting for leverage decay and daily rebalancing effects. This type of leveraged product is highly sensitive to intraday and daily moves in its benchmark. Without access to RCAT's price action or broader market conditions on 2026-07-21, the most plausible explanation remains a significant rally in the underlying asset class, technical buying, or institutional rebalancing rather than company-specific news.

BTDL

GraniteShares 2x Long BTDR Daily ETF

$25.52+$4.31

+20.3%

NASDAQ

No news headlines were found in the last 48 hours, so the +20.33% gain likely reflects a sharp move in the underlying BTDR cryptocurrency or Bitcoin asset that the leveraged ETF tracks, amplified by its 2x daily structure.

BTDL is a 2x leveraged daily ETF tracking BTDR, meaning price movements in the underlying asset are mechanically amplified by a factor of approximately two on a daily basis. With no news provided, the +20.33% jump is not attributable to company-specific or fund-specific announcements. Instead, this move almost certainly reflects a significant intraday rally in Bitcoin or the BTDR index itself, likely driven by either a crypto market-wide rally, positive sentiment in digital assets, technical breakout, or institutional buying. The 2x leverage structure means a roughly 10% move in the underlying would produce approximately a 20% move in the ETF, which aligns with today's observed gain. Without access to BTDR price data or crypto market news from the snapshot date, we cannot identify the specific catalyst.

HOVR

New Horizon Aircraft LtdIndustrials

$1.99+$0.34

+20.2%

NASDAQ · Mkt cap $132 M

New Horizon Aircraft announced a letter of intent with V-Star Powered Lift Aviation for the purchase of up to 100 hybrid eVTOLs worth $600 million, likely driving the 20% gain as a significant commercial validation in the emerging urban air mobility sector.

The headline from July 21 at 12:00 UTC reports that Horizon Aircraft has secured a letter of intent with V-Star for purchase of up to 100 hybrid-electric Cavorite X7 VTOLs valued at $600 million. This represents a material near-term commercial win for a small-cap aircraft manufacturer. For microcap companies in emerging aerospace technology, large purchase commitments and fleet orders are typically celebrated by markets as proof of demand and a pathway to revenue. The contract's focus on Australian emergency air response adds a concrete use case. The timing aligns with the stock's 20% move, and this type of announcement is exactly the sort of catalyst microcap investors monitor. The second headline about RedChip's investor conference is generic promotional content unlikely to drive stock action. No contradictory news or broader market context is evident.

MTC

MMTec, Inc.Financial Services

$3.15+$0.53

+20.2%

EXOD

Exodus Movement, Inc.Technology

$5.56+$0.92

+19.8%

SUGP

SU Group Holdings Limited Ordinary SharesIndustrials

$0.54+$0.09

+19.8%

NASDAQ · Mkt cap $6.9 M

No news headlines were found in the last 48 hours, so the 19.8% gain likely reflects a technical rebound, delayed reaction to an earlier announcement, or a micro-cap volatility event rather than a newly disclosed catalyst.

SUGP is a micro-cap security trading at $0.54 with no reported news in the prior two days to explain the 19.80% single-day jump. Without headlines identifying a specific catalyst such as earnings, a contract award, financing news, or regulatory action, the driver remains unclear. Possible explanations include a technical bounce off support levels common in low-priced stocks, reaction to stale news from earlier in the week that delayed market processing, short covering in a thinly-traded name, or retail trading interest unaccompanied by company-initiated disclosure. Micro-cap and penny stocks are prone to volatility swings on light trading volume and retail coordination, none of which would typically trigger headline coverage. Without structural insight into SUGP's business model or capital structure, a definitive cause cannot be determined from available evidence alone.

FEIM

Frequency Electronics, Inc.Technology

$79.85+$13.13

+19.7%

NASDAQ · Mkt cap $669 M

FEIM surged 19.67% after reporting a Q4 loss driven by restructuring costs, but the market focused on record backlog, strong bookings, and reaffirmed three-year growth targets that signal future profitability recovery.

The headline establishes that FEIM reported a fiscal Q4 loss per share stemming from restructuring and upfront investments. Despite the near-term loss, the company disclosed record backlog and strong bookings alongside reaffirmed three-year financial targets. Market interpretation appears to have weighted the forward-looking fundamentals—particularly the record backlog as a revenue pipeline indicator—more heavily than the current quarterly loss. This is a common pattern in cyclical and defense/aerospace-adjacent businesses where near-term restructuring pain is tolerated if management simultaneously strengthens the pipeline and maintains confidence in medium-term guidance. The 19.67% gain reflects investor relief that the loss was explained as temporary and strategic rather than indicative of operational deterioration.

FEMY

Femasys Inc.Healthcare

$3.91+$0.64

+19.6%

NASDAQ · Mkt cap $22 M

No news headlines were found in the last 48 hours, so the 19.57% gain cannot be attributed to a specific announced event. The move likely reflects technical factors, delayed press release pickup, or small-cap volatility.

Femasys is a small-cap medical device company, and the absence of any news in the Yahoo Finance RSS feed over the past two days creates ambiguity about what drove the jump. For stocks of this size and sector, significant moves can occur from several sources: delayed dissemination of press releases that did not yet appear in aggregators, technical or short-covering activity, insider buying signals, clinical trial updates, regulatory feedback, or analyst coverage initiation. Without headline evidence, the specific trigger remains unknown. Small-cap healthcare stocks are particularly sensitive to microvolumes and information asymmetries, which can amplify moves on limited volume or triggered stops.

COIA

ProShares Ultra COIN

$9.09+$1.46

+19.1%

AMEX

No news headlines were found in the last 48 hours; the 19% gain in COIA is most likely driven by a sharp rally in Bitcoin or the broader cryptocurrency market, since this is a 2x leveraged Bitcoin ETF that amplifies daily moves in its underlying.

COIA is the ProShares Ultra COIN, a 2x leveraged ETF designed to deliver double the daily returns of the Grayscale Bitcoin Mini Trust (BTC). Because it uses leverage, a 9-10% move in Bitcoin would produce roughly an 18-20% move in COIA, which matches today's performance precisely. No company-specific news or regulatory announcement appears in the headline feed, so the driver is almost certainly movement in Bitcoin itself rather than any COIA-specific event. This type of leveraged product responds mechanically to its underlying, so a strong Bitcoin day would automatically produce an outsized gain here. Without access to Bitcoin's price action or cryptocurrency-sector news from the past 48 hours, I cannot confirm the exact catalyst, but this is the most parsimonious explanation.

WBUY

WEBUY GLOBAL Ltd. Ordinary SharesConsumer Cyclical

$0.75+$0.12

+19.1%

NASDAQ · Mkt cap $4.2 M

Webuy announced a strategic partnership with Moyu Travel and MeetPanda to expand China inbound travel capabilities, likely driving the 19.12% gain as investors responded positively to growth expansion in the travel tech sector.

The headline from July 20 indicates Webuy Global entered into a Memorandum of Understanding to expand its China inbound travel capabilities through partnerships with Moyu Travel and MeetPanda. This represents a concrete business development announcement in a key market for travel technology. The stock jumped approximately 19 hours after the announcement, which is a reasonable lag for news dissemination and market reaction. The partnership signals growth strategy execution in China, a large travel market. However, the full details of the partnership (revenue impact, exclusivity terms, timeline) are truncated in the provided headline, so we cannot assess the magnitude of strategic importance from the text alone. For a stock trading at $0.75, positive growth announcements can generate outsized percentage moves, particularly if the company has a small float or limited institutional coverage.

CJMB

Callan JMB Inc. Industrials

$1.44+$0.23

+19.0%

NASDAQ · Mkt cap $15 M

No news headlines were found in the last 48 hours, so the 19% gain on CJMB cannot be attributed to any announced corporate event; the catalyst is likely technical, sentiment-driven, or based on information not yet reflected in public headlines.

Callan JMB Inc. posted a significant single-day gain of 19% to reach $1.44 on July 21, 2026, but no news articles appeared in the Yahoo Finance RSS feed during the preceding 48 hours. This absence of headline-driven catalysts suggests the move may stem from technical factors such as short covering, algorithmic trading on low volume, momentum from prior sessions, or retail sentiment shifts that precede formal news releases. Penny stocks and low-priced equities like CJMB are particularly prone to sharp single-day swings on limited volume without accompanying news. It is also possible that material news was released outside the captured RSS feeds, through direct company announcements, SEC filings, or wire services not immediately syndicated. Without access to the company's fundamentals, recent earnings performance, or current market conditions, it is impossible to rule out operational or market-specific factors that may have triggered buying interest.

CONL

GraniteShares 2x Long COIN Daily ETF

$5.96+$0.95

+19.0%

NASDAQ

No news headlines were found in the last 48 hours, but CONL is a 2x leveraged ETF tracking Coinbase (COIN), so an 18.96% gain likely reflects a strong move in the underlying cryptocurrency or exchange stock, amplified by its daily reset mechanism.

The absence of any news in the provided headlines means we cannot point to a specific catalyst. However, CONL's structure itself offers a clear lens for interpretation. As a 2x long daily ETF on Coinbase, it amplifies moves in COIN by roughly double on a daily basis. An ~9-10% move in COIN would translate to roughly an 18-20% move in CONL, which aligns with the observed gain. The likely causes therefore fall into categories typical for COIN: a rally in Bitcoin or Ethereum prices, positive cryptocurrency market sentiment, a bullish analyst note or regulatory development affecting crypto exchanges, or broad risk-on equity flows. Without access to intraday COIN performance or crypto market data for 2026-07-21, we cannot definitively isolate which factor drove the move, only that the magnitude is consistent with CONL's leverage ratio responding to an underlying COIN rally.

RGC

Regencell Bioscience Holdings LimitedHealthcare

$6.06+$0.96

+18.8%

NASDAQ · Mkt cap $2.9 B

No news headlines were found in the last 48 hours to explain RGC's 18.82% jump. The move likely stems from a delayed announcement, technical rebound, or retail trading activity typical of micro-cap biotech stocks.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it difficult to pinpoint a specific catalyst for Regencell Bioscience's strong gain. RGC is a small-cap biotech company, and stocks in this category often experience outsized intraday moves driven by factors other than same-day news announcements. Possible explanations include: a press release or filing that has not yet been indexed by news aggregators; positive clinical trial data or partnership news released before the 48-hour window; or technical/algorithmic trading responding to accumulated buying pressure. Micro-cap biotech stocks are also prone to gap moves based on sentiment shifts, short covering, or discussions in retail trading communities. Without corroborating headlines, the specific driver remains unclear.

NBIS

Nebius Group N.V.Communication Services

$216.92+$34.30

+18.8%

NASDAQ · Mkt cap $61 B

Nvidia disclosed a 9.3% stake in Nebius worth approximately $4 billion, deepening ties between the chipmaker and the AI cloud provider and signaling strong confidence in the company's growth prospects in the booming AI infrastructure market.

The news headlines establish a single clear catalyst: on July 21, Nvidia announced it had acquired a 9.3% passive stake in Nebius Group, representing roughly 22.26 million shares and valued at nearly $4 billion. This stake was reportedly 18 times larger than a previous Nvidia position, indicating a substantial deepening of the relationship. The disclosure triggered immediate buying pressure, with the stock jumping 13% on initial reports and finishing the day up 18.78%. Multiple analysts, including Freedom Capital, issued upgrades the same day, citing the Nvidia endorsement as validation of Nebius's competitive position in the high-growth AI cloud computing market. An insider sale of $1.4 million by the chairman also occurred but appears secondary to the Nvidia news given the magnitude and timing of the stock reaction. The market interpreted Nvidia's large stake purchase as a strong signal of confidence in Nebius's technology and market opportunity, consistent with this being the company's third consecutive day of gains.

CONX

Direxion Daily COIN Bull 2X ETF

$7.21+$1.13

+18.6%

NASDAQ

No news headlines were found in the last 48 hours, but CONX is a 2x leveraged Bitcoin ETF that amplifies daily moves in the underlying COIN index or Bitcoin itself, so the +18.63% jump likely reflects a sharp rally in cryptocurrency markets on the day.

The absence of any headlines in the search results makes it impossible to identify a specific company or market-wide news event. However, CONX's structural design as a daily 2x bull leveraged ETF means it automatically amplifies the daily percentage move of its underlying asset by a factor of two. If the cryptocurrency market or the COIN index rallied sharply on July 21, 2026, the ETF would be expected to double that move. A move of roughly +9% in the underlying would translate to the observed +18.63% in CONX. The most likely driver is therefore a significant intraday rally in Bitcoin or the broader crypto market, which would be a natural fit for this security's volatility profile and leverage structure. Without access to actual market data or news from that specific trading day, attribution remains inference rather than confirmed fact.

COIG

Leverage Shares 2x Long COIN Daily ETF

$5.84+$0.92

+18.6%

NASDAQ

No news headlines were found in the last 48 hours, but COIG is a 2x leveraged ETF tracking Coinbase stock, so an 18.62% gain likely reflects a strong move in the underlying COIN or crypto market strength.

No recent news headlines were provided to explain this move directly. However, COIG is a structured product with 2x daily leverage on Coinbase (COIN), meaning it amplifies the daily performance of its underlying asset by a factor of two. An 18.62% gain in COIG would imply roughly a 9% gain in COIN on the day, or a similar magnitude move in cryptocurrency markets that influence Coinbase. Without headlines, the most likely catalysts are either a significant intraday rally in Bitcoin or Ethereum, positive industry developments not yet captured in the RSS feed lag, or broader market sentiment shift toward crypto assets. This kind of stock typically responds to Bitcoin price action, regulatory announcements, or Coinbase-specific business news.

SWMR

Swarmer, Inc Common StockTechnology

$46.18+$7.10

+18.2%

NASDAQ · Mkt cap $452 M

No news headlines were available in the last 48 hours, so the 18.17% gain likely stems from a delayed earnings release, analyst upgrade, insider transaction, or technical/sentiment catalyst that has not yet appeared in the RSS feed.

The absence of headlines in the provided news snapshot creates genuine uncertainty about what drove Swarmer's strong 18% rally to rank it among the day's top 50 gainers. For a stock of this apparent size and liquidity to move this sharply, a material catalyst would typically be expected, such as quarterly earnings results (beat or strong guidance), an analyst initiation or price target raise, a merger or partnership announcement, insider buying, or a short squeeze or technical breakout. Without access to real-time market data, press releases, or broader financial news feeds beyond the Yahoo Finance RSS provided, we cannot confirm which of these categories—if any—actually triggered the move. The gap between the magnitude of the move and the absence of reported news could indicate the catalyst is very recent, not yet indexed by the RSS feed, or occurring through channels outside mainstream financial news distribution.

Biggest Losers

Tue, Jul 21, 2026 50

LBGJ

Li Bang International Corporation Inc. Ordinary SharesIndustrials

$0.06−$0.16

-73.1%

NASDAQ · Mkt cap $58 K

No news headlines were found in the last 48 hours, so the 73% plunge cannot be attributed to a specific announced catalyst; the cause remains unclear without additional context.

A 73% single-day collapse in a stock trading at $0.06 is extreme and typically driven by a major catalyst, yet no headlines appeared in the search window covering the past two days. This absence of news does not rule out a catalyst—delayed reporting, after-hours announcements, insider warnings, or delisting/compliance threats can move penny stocks sharply without immediate media coverage. Alternatively, the move could reflect technical liquidation, margin calls, a failed capital raise, regulatory action not yet widely reported, or short-squeeze unwinding. Without news or structural detail about LBGJ's business, capitalization, or recent filings, only generic categories of cause are plausible.

ZYBT

Zhengye Biotechnology Holding LimitedHealthcare

$2.85−$5.16

-64.4%

NASDAQ · Mkt cap $88 M

Zhengye Biotechnology plunged 64% on unusual trading volume, but the company explicitly stated on July 21 that it is unaware of any material undisclosed events explaining the move, leaving the true catalyst unknown.

The company's own statement denying knowledge of material developments that would justify the trading activity is striking and unusual. This suggests the move was either driven by external speculation, technical factors, or information not yet disclosed to management. For a China-based veterinary vaccine manufacturer trading on NASDAQ, typical catalysts include regulatory actions, clinical trial results, competitive pressures, or broader sector selloffs. The denial itself does not reveal what triggered the initial surge in volume and subsequent crash. Without concrete news of earnings misses, FDA actions, contract losses, or delisting threats, the underlying cause remains opaque. The stock's position as the second-largest loser despite management's assurance of no known issues underscores investor panic or positioned short interest unwind.

CLBK

Columbia Financial, Inc.Financial Services

$11.08−$13.42

-54.8%

NASDAQ · Mkt cap $1.2 B

Columbia Financial announced completion of a second step conversion, $1.7 billion stock offering, and acquisition of Northfield Bancorp on July 20, likely causing substantial dilution that drove the 54.78% stock price collapse.

The headline confirms Columbia Financial completed a second step conversion and a $1.7 billion stock offering concurrent with acquiring Northfield Bancorp. A second step conversion typically involves converting a mutual holding company to stock form, which includes a large capital raise via new share issuance. The combination of a $1.7 billion offering plus the acquisition announcement on July 20 would trigger immediate dilution concerns among existing shareholders. Markets often react negatively to large equity offerings announced suddenly, particularly when coupled with M&A activity, because they signal both near-term share dilution and potential integration risks. The 54.78% single-day decline suggests the market viewed the capital structure change and offer terms as significantly value-destructive to current holders, which is a typical pattern for second step conversions where the mutual conversion mechanism itself can be unfavorable to converted shareholders.

LSTA

Lisata Therapeutics, Inc.Healthcare

$2.24−$1.29

-36.5%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours, so the 36% drop cannot be directly attributed to a disclosed event; the decline likely reflects a clinical setback, trial result, regulatory decision, or broader biotech selloff for a small-cap therapeutic company.

Lisata Therapeutics is a small-cap biopharmaceutical company, and a 36% single-day loss of this magnitude in the absence of disclosed news is atypical but not unprecedented in the biotech sector. Common catalysts for such moves in companies like this include negative clinical trial results, FDA regulatory decisions (refusals or clinical holds), unexpected management changes, financing dilution announcements, or sharp revisions to development timelines. Because no headlines appear in the Yahoo Finance RSS feed within 48 hours, either the news has not yet been widely picked up, was released outside the RSS feed window, or occurred through a channel not captured here. Biotech stocks are also sensitive to sector-wide sentiment shifts and short-covering events. Without access to the company's recent press releases, SEC filings, or clinical pipeline updates, the precise driver remains unknown, though a clinical or regulatory event is statistically most likely given the company type and severity of the move.

MWC

Micware Co., Ltd. American Depositary SharesConsumer Cyclical

$1.11−$0.58

-34.3%

NASDAQ · Mkt cap $88 M

No news headlines were found in the last 48 hours, so the 34% drop cannot be attributed to a specific announced event; the cause likely stems from an undisclosed development, technical selling, or market dynamics not captured in available headlines.

The absence of recent news headlines is notable given MWC's position as the fifth biggest loser on the day with a severe 34% decline. This magnitude of move typically correlates with material corporate announcements such as earnings misses, guidance cuts, insider selling, regulatory setbacks, or capital structure changes. Without headlines to confirm any specific catalyst, the drop could reflect several possibilities: delayed negative news not yet indexed by RSS feeds, after-hours developments, a technical breakdown in a thinly traded security, a short squeeze reversal if the stock had been elevated on low float trading, or sector-wide pressure affecting small-cap ADRs. The lack of concurrent news coverage is itself noteworthy and suggests either that the catalyst has not yet been publicly disclosed or amplified through major financial media channels.

QMLS

QumulusAI, Inc. Common StockTechnology

$6.81−$2.68

-28.2%

NASDAQ · Mkt cap $235 M

QumulusAI announced a major GPU purchase from NVIDIA on July 20, which would normally be positive, but the 28% drop suggests the market viewed the capex commitment as concerning given potential profitability or cash runway issues.

The headline reports QumulusAI purchased 1,632 NVIDIA Blackwell B300 GPUs to meet customer demand, framed as a bullish signal. However, a severe single-day drop of this magnitude following a capex announcement typically indicates market skepticism about the company's ability to profitably deploy this capital or concerns about balance sheet strain. The market may be reacting to the sheer scale of the purchase commitment and what it implies about near-term cash burn, debt levels, or unit economics. Alternatively, investors may have interpreted the announcement as signaling desperation to secure GPUs before they become unavailable, raising questions about competitive positioning or prior underinvestment. Without access to the full press release, Q2 earnings, or forward guidance, we cannot confirm whether management disclosed financial metrics that triggered the sell-off, but large capex announcements in infrastructure stocks often provoke repricing when investors lack confidence in ROI.

PYPD

PolyPid Ltd.Healthcare

$3.74−$1.41

-27.4%

NASDAQ · Mkt cap $91 M

PolyPid announced an exclusive partnership with Azurity to commercialize D-PLEX100 in the U.S. and Canada, but the market interpreted the deal terms—including potential $320M in payments and mid-teen to mid-twenties royalties—as unfavorable, triggering a 27% sell-off.

On the surface, a major commercialization partnership with over $320 million in upfront and milestone payments should be positive for a biotech company. However, the market's sharp negative reaction suggests investors viewed the deal structure as dilutive or the royalty tiers as underwhelming. The royalty range of mid-teen to mid-twenties percentages may have disappointed holders who expected higher economics, or the exclusivity arrangement may be seen as limiting PolyPid's optionality. Additionally, partnering away commercial rights rather than retaining them in-house typically results in lower upside capture than full ownership. Without visibility into deal timing, probability-adjusted present value, or analyst commentary, the exact source of the disappointment cannot be pinpointed, but valuation compression following a licensing deal often reflects skepticism about the company's ability to generate higher returns independently.

SKDD

GraniteShares 2x Short SK Hynix Daily ETF

$12.43−$4.63

-27.1%

NASDAQ

No headlines were published in the last 48 hours to explain the 27% drop in this leveraged inverse ETF, but the most likely cause is a sharp rally in SK Hynix or the broader semiconductor sector that automatically amplifies losses in a 2x short product.

SKDD is a 2x leveraged inverse ETF tracking SK Hynix, meaning it is designed to move negative two times the daily performance of its underlying stock. When SK Hynix gains significantly on any catalyst—earnings beat, sector strength, geopolitical relief, or technical breakout—this ETF will experience outsized losses. With no news headlines provided in the last 48 hours, the drop cannot be attributed to a specific SKDD-related announcement. The most probable explanation is that SK Hynix rallied sharply on semiconductor bullishness, positive earnings, or broader chip sector tailwinds, which would mechanically drive this inverse product down with 2x amplification. This is typical daily behavior for leveraged inverse ETFs during positive moves in their underlying assets. Without access to SK Hynix price action or sector news, we cannot confirm the exact trigger.

PHOE

Phoenix Asia Holdings Limited Ordinary SharesIndustrials

$26.60−$9.90

-27.1%

NASDAQ · Mkt cap $526 M

No news headlines were found in the last 48 hours, so the cause of the 27.12% drop cannot be determined from available public information; the decline likely stems from company-specific news, earnings, guidance, or market sentiment not yet reflected in the RSS feed.

Phoenix Asia Holdings Limited experienced a significant single-day loss of 27.12%, ranking it among the day's nine biggest losers. However, no recent news headlines appear in the provided RSS feed from the last 48 hours. This disconnect between a material price move and the absence of contemporaneous news coverage is notable. For a stock moving this sharply, typical catalysts include earnings misses, negative guidance revisions, executive departures, regulatory issues, or sector-wide selloffs. Since no headlines are available, the move may reflect news released outside the monitored sources, delayed market reaction to older news, or deterioration in underlying business conditions. A check of company earnings releases, regulatory filings, or news from regional financial sources would be necessary to identify the actual catalyst.

GVH

Globavend Holdings LimitedIndustrials

$1.10−$0.38

-25.7%

NASDAQ · Mkt cap $2.4 M

GVH fell 25.68% despite announcing a favorable distribution deal with DramaBox on July 20th, suggesting the market either viewed the announcement as priced-in, disappointing on financial terms, or reacted to an unrelated negative catalyst not captured in the provided headlines.

The two headlines from July 20th both report the same positive news: Globavend's Loomi Entertainment Group signed a global distribution agreement with DramaBox, a platform with over 90 million registered users, to distribute AI-produced English-language micro dramas. This is a commercial expansion announcement that would normally be expected to support or lift the stock. However, the stock dropped sharply the day after the announcement closed. This disconnect suggests either the market found the terms or financial implications underwhelming, already knew about the deal and had priced it in, or the sell-off was driven by a separate catalyst not reflected in the provided news feed—such as earnings results, analyst downgrades, sector rotation, or company-specific operational issues announced through other channels.

KUST

Kustom Entertainment, Inc.Communication Services

$0.96−$0.31

-24.3%

NASDAQ · Mkt cap $1.8 M

No headlines were found in the last 48 hours, so the 24.34% drop cannot be directly attributed to a specific news event. The cause is likely a delayed announcement, technical sell-off, or market rumor not yet captured in major financial RSS feeds.

The absence of recent news headlines makes it difficult to pinpoint a concrete catalyst for KUST's significant intraday decline. Micro-cap and penny stocks like KUST, trading at $0.96, are highly susceptible to several types of moves unrelated to broad market news: reverse splits, delisting warnings, failed business developments, insider trading disclosures, or sudden liquidity crunches. Additionally, low-float stocks in the entertainment sector can experience sharp reversals on technical factors, accumulation/distribution patterns, or social media-driven sentiment shifts that may not be formally reported by mainstream financial outlets within 48 hours. The stock's rank as the 11th biggest loser suggests genuine selling pressure rather than a broad index decline, indicating an entity-specific or sector-specific catalyst. Without corroborating headlines, the most likely explanations remain delayed SEC filings, private news flow not yet public, or technical capitulation.

MUZ

Defiance Daily Target 2X Short MU ETF

$12.09−$3.79

-23.9%

AMEX

No news headlines were available in the last 48 hours, but MUZ is a 2X inverse leveraged ETF on Micron Technology, so a significant rally in MU stock would cause MUZ to fall sharply on the inverse multiplier effect.

MUZ tracks the daily performance of Micron Technology (MU) with a 2X short leverage structure, meaning it gains when MU falls and loses when MU rises. The 23.87% decline in MUZ strongly suggests MU rallied approximately 12% or more on the day, which would be consistent with a major positive catalyst in semiconductor or memory markets. Without news headlines provided, the most likely catalysts for a sharp MU move would be stronger-than-expected earnings or guidance, positive industry commentary, or a broad semiconductor sector rally. Since this is a leveraged inverse ETF, daily volatility and rebalancing effects also amplify the underlying move, but the magnitude of the loss indicates a substantial move in MU itself rather than a structural issue with the fund.

WCT

Wellchange Holdings Company LimitedTechnology

$0.82−$0.25

-23.8%

NASDAQ · Mkt cap $4.1 M

No news headlines were reported in the last 48 hours for WCT, so the 23.8% drop cannot be directly attributed to any announced event. The decline likely reflects technical selling, market-wide pressure, or unreported corporate news.

The absence of any headlines in the Yahoo Finance RSS feed over the past two days makes it impossible to link the sharp 23.8% decline to a specific catalyst. For a micro-cap stock trading near $0.82, typical drivers of large single-day losses include technical support breaks, short-term liquidity events, delayed earnings announcements, insider selling, or adverse developments that may not yet appear in mainstream financial news wires. Wellchange Holdings is a smaller-cap company, and information about such firms sometimes surfaces through regulatory filings or press releases before reaching major news aggregators. Without headline confirmation, we cannot determine whether this is a temporary technical move or reflects genuine deterioration in fundamentals or forward guidance.

SLND

Southland Holdings, Inc.Industrials

$0.80−$0.24

-22.8%

AMEX · Mkt cap $32 M

No news headlines were found in the last 48 hours to explain SLND's 22.85% drop on July 21, 2026, so the catalyst remains unknown based on available information.

The absence of recent news headlines is the first constraint here. A drop of this magnitude (nearly 23%) typically correlates with a material negative event: earnings disappointment, guidance cut, insider selling disclosure, debt or covenant concerns, loss of a major contract, regulatory action, or broader market contagion. For a company trading at $0.80 on a major exchange, possible causes in the infrastructure or equipment rental sector that SLND operates in could include credit facility issues, quarterly results that missed expectations, analyst downgrades, or a delayed SEC filing. Without headlines or a specific structural insight into SLND's current capital structure or known vulnerabilities, the move remains unexplained by the available data set. The timing and magnitude suggest something material happened, but determining what would require access to real-time market news, SEC filings, or social media chatter that is not provided here.

CCG

Cheche Group Inc.Communication Services

$11.71−$3.46

-22.8%

NASDAQ · Mkt cap $34 M

No news headlines were published in the last 48 hours for CCG, so the 22.81% drop cannot be attributed to a specific disclosed event; the cause remains unclear without access to intraday catalysts or market commentary.

The absence of recent news is noteworthy given the magnitude of the move. CCG dropped 22.81% to rank as the 15th biggest loser of the day, yet no headlines appeared in the Yahoo Finance RSS feed over the preceding 48 hours. This disconnect suggests either that the catalyst occurred outside the monitored news cycle, that it is a technical or sentiment-driven move, or that material information was released through channels not captured in standard financial news feeds. Without knowing CCG's sector, business model, or current market conditions, plausible hypotheses include: a delayed market reaction to a prior untracked announcement; negative guidance or earnings revision communicated via earnings call rather than press release; or a broader sector rotation or technical breakdown. Any explanation at this point is speculative.

GORO

Goldgroup Mining Inc.Basic Materials

$2.58−$0.71

-21.6%

AMEX · Mkt cap $208 M

Goldgroup's 21.6% drop on July 21 likely reflects dilution concerns following Eric Sprott's acquisition of 2.55 million shares announced July 20, though an updated technical report was also filed simultaneously, making the precise driver unclear.

Two news items crossed the wire on July 20 that could have triggered the decline. Eric Sprott's entity acquired 2.55 million shares of Goldgroup, which typically signals confidence but can also raise dilution or control concerns among existing shareholders, especially if the terms or timing were viewed as unfavorable. Concurrently, Goldgroup filed an updated technical report, which could have contained revised resource estimates, project economics, or timeline adjustments that disappointed investors. Neither headline explicitly states negative guidance or downward revisions, so the exact catalyst remains ambiguous. Mining stocks are also sensitive to commodity prices, sentiment shifts, and insider activity interpretation, any of which could have contributed to the sharp single-day selloff. The Sprott involvement and updated technical report timing suggest news-driven rather than purely technical selling, but without details on the report's contents or the share acquisition terms, confidence in a single root cause is limited.

TGHL

Growhub LtdTechnology

$0.58−$0.16

-21.3%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours for TGHL, so the 21.32% drop cannot be attributed to a specific announced event; the decline likely reflects technical selling, sector weakness, or an unannounced company development.

The absence of recent news makes it difficult to pinpoint a direct catalyst for TGHL's sharp 21.32% decline. At a stock price of $0.58, TGHL appears to be a micro-cap security where price movements can be volatile and driven by factors other than major news announcements. Possible explanations for the drop without supporting headlines include technical selling after a prior rally, broad market sector weakness affecting growth or tech-focused companies, insider trading activity, delayed disclosure of company developments, or speculative trading in low-liquidity stocks. Without access to company filings, insider transactions, or breaking news outside the provided RSS feed, we cannot determine which explanation applies. Investors should check the company's latest 8-K filings, earnings calendar, and insider trading records to rule out material undisclosed events.

TDWDR

Tailwind 2.0 Acquisition Corp. Rights

$0.13−$0.04

-21.2%

NASDAQ

No news headlines were found in the last 48 hours, but the 21% drop in a SPAC rights offering likely reflects typical volatility in low-liquidity warrant/rights securities or a deterioration in confidence in the underlying merger target.

Tailwind 2.0 Acquisition Corp. Rights (TDWDR) is a SPAC rights security, which typically trades with extreme sensitivity to sentiment around the merger target and deal completion risk. The absence of breaking news in the past 48 hours does not rule out older developments from earlier in the week that may still be driving repricing, nor does it exclude technical factors common to low-volume, penny-range securities. Rights offerings are particularly volatile because they represent call options on the SPAC's post-merger equity and lose value as deal deadlines approach or confidence erodes. The large single-day loss could reflect increased merger uncertainty, a deadline extension announcement from before the snapshot window, redemption concerns, or simply thin order flow amplifying a small shift in demand. Without current news or visibility into SPAC deal status, the most likely category remains deal execution risk or liquidity-driven repricing rather than a discrete news event.

ADVB

Advanced Biomed Inc. Common StockHealthcare

$7.08−$1.82

-20.4%

NASDAQ · Mkt cap $14 M

No news headlines were found in the last 48 hours, so the 20.45% drop cannot be directly attributed to a announced event; the cause likely involves a delayed press release, insider news flow, technical selling, or sector headwinds affecting the biomedical space.

The absence of any Yahoo Finance headlines in the prior 48 hours makes it impossible to pinpoint a specific catalyst for ADVB's sharp 20.45% decline. For a small-cap biomedical stock, common catalysts include clinical trial results, FDA decisions, funding announcements, or guidance revisions that may not always appear immediately in major RSS feeds or may be announced through less widely syndicated channels. Alternatively, the move could reflect technical selling pressure from a breakdown in support levels, sector-wide biotech weakness, or an undisclosed development that has reached retail investors through social media or smaller news outlets before major wire services picked it up. Without direct evidence of what triggered the decline, attributing causation would be speculative.

CRACR

Crown Reserve Acquisition Corp. I Rights

$0.12−$0.03

-19.7%

NASDAQ

No news headlines were published in the last 48 hours. The 19.73% drop in Crown Reserve Acquisition Corp. I Rights is likely driven by typical SPAC warrant/rights dynamics, redemption risk, or broader market weakness, but the specific trigger cannot be identified without additional information.

Crown Reserve Acquisition Corp. I Rights is a SPAC-related security, which are inherently volatile instruments subject to sharp moves based on deal progression, redemption announcements, or shifts in investor sentiment toward blank-check companies. Rights and warrants in SPACs are particularly sensitive to changes in underlying merger timelines, funding conditions, or announcement of a definitive merger agreement. The absence of any news headlines in the past 48 hours suggests the move was driven either by internal SPAC developments not yet covered by major news feeds, technical selling or redemption pressure, broader SPAC market weakness, or possible news on alternative sources like company press releases or SEC filings that Reuters/Yahoo have not yet indexed. Without access to recent SEC filings or the underlying SPAC's investor communications, pinpointing the exact catalyst is not possible.

CONI

GraniteShares 2x Short COIN Daily ETF

$40.45−$9.51

-19.0%

NASDAQ

No headlines were published in the last 48 hours, but CONI is a 2x inverse leveraged ETF tracking Coinbase, so a sharp 19% drop likely reflects a strong rally in the underlying COIN stock that amplified through the inverse leverage mechanism.

CONI holds an inverse relationship to Coinbase (COIN) with 2x daily leverage, meaning it profits when COIN declines and loses sharply when COIN rises. The absence of any news headlines in the provided data makes direct event attribution impossible. However, the structural nature of this security offers a clear explanation: a significant rally in COIN would mechanically push CONI down at approximately twice the magnitude. Without access to COIN's intraday performance or broader crypto market moves on 2026-07-21, we cannot confirm the specific catalyst, but inverse leveraged ETFs are highly sensitive to directional moves in their underlying assets. The drop could also reflect decay from daily rebalancing if COIN showed volatility, a common risk in leveraged instruments.

CDTG

CDT Environmental Technology Investment Holdings Limited ordinary sharesIndustrials

$1.01−$0.23

-18.5%

NASDAQ · Mkt cap $9.9 M

No news headlines were found in the last 48 hours for CDTG, so the cause of the 18.55% drop cannot be directly attributed to a disclosed event. The move likely reflects either market-wide headwinds, sector rotation, or undisclosed company developments.

The absence of recent news makes it impossible to pinpoint a specific catalyst for CDTG's sharp 18.55% decline. Given the stock's low price of $1.01 and position as a micro-cap environmental technology investment vehicle, the move could reflect several plausible but unconfirmed factors. CDT Environmental holds interests in environmental and clean technology assets, sectors that respond to shifts in policy sentiment, funding availability, and ESG-driven capital flows. A drop of this magnitude in a lower-liquidity stock could also result from technical selling, margin calls on leveraged positions, or delayed disclosure of material adverse events that have not yet appeared in major news feeds. Without confirmed headlines, the specific trigger remains unknown.

NTCL

NetClass Technology IncTechnology

$3.21−$0.73

-18.5%

NASDAQ · Mkt cap $3.3 M

No news headlines were found in the last 48 hours to explain NetClass Technology's sharp 18.53% decline on July 21, 2026, so the cause remains unclear without additional information.

Yahoo Finance returned no news items for NTCL in the past two days, which means we cannot point to a specific catalyst such as earnings disappointment, guidance cut, insider selling, analyst downgrade, regulatory action, or business development announcement. A drop of this magnitude in a micro-cap stock like NTCL, currently trading at $3.21, could theoretically stem from sector rotation, short covering, a delayed news release not yet indexed by the RSS feed, technical selling following a prior rally, or deteriorating market sentiment toward technology equities broadly. Without access to the company's stock history, insider transactions, or broader market context for that date, we cannot distinguish between a fundamental repricing and a technical event. The absence of news coverage itself is notable and suggests either the move is driven by technical factors or the newsworthy event has not yet been widely reported.

VTIX

Virtuix Holdings Inc. Class A Common StockTechnology

$2.29−$0.50

-17.9%

NASDAQ · Mkt cap $55 M

The provided news headline about Omni One's XR award appears unrelated to Virtuix's 17.92% decline. The drop likely stems from broader market sentiment, technical weakness, or undisclosed company-specific news not captured in the headline sample.

The single headline references Omni One, a competing or separate entity in the XR space, winning an industry award for humanoid robotics and AI teleoperation. This news does not directly address Virtuix's business, financial performance, or strategic position. While both operate in extended reality markets, the headline does not establish a causal link to Virtuix's stock drop. The magnitude of the decline (nearly 18%) suggests a material catalyst, but without earnings reports, guidance changes, product delays, competitive announcements specifically from Virtuix, or broader market data, the root cause remains unclear. Possibilities include selling pressure tied to low liquidity in a micro-cap stock, technical breakdown below a key support level, or significant company news released outside this 48-hour window.

ATER

Aterian, Inc.Consumer Cyclical

$1.03−$0.22

-17.6%

NASDAQ · Mkt cap $5.0 M

ATER fell 17.6% on heavy selling with zero news reported in the last 48 hours, indicating either a technical breakdown, delayed negative disclosure, or market-wide pressure unrelated to fresh company developments.

No headlines were available in the last 48 hours to explain the sharp 17.6% decline in ATER. This absence of news during a top-25 losing day suggests either a technical event such as a stop-loss cascade, an intraday rumor not yet reported by major news feeds, or a sector-wide selloff affecting micro-cap retail-commerce plays. ATER is a highly volatile consumer e-commerce platform with a history of being sensitive to retail sentiment and short-seller activity. Without a concrete catalyst reported, the most likely explanations are technical capitulation, a delayed earnings disappointment, debt covenant concerns, or execution stumbles not yet reflected in wire reports. The stock's low price and high volatility make it susceptible to rapid sentiment reversals without major headline support.

FIGG

Leverage Shares 2x Long FIG Daily ETF

$19.76−$4.20

-17.5%

NASDAQ

No news was reported in the last 48 hours, but FIGG is a 2x leveraged ETF tracking Figueroa Inc (FIG), so a sharp single-day drop most likely reflects a corresponding decline in the underlying stock, amplified by the leverage structure.

The absence of any headlines in the last 48 hours means we cannot identify a specific company-level catalyst. However, FIGG is a structured product that magnifies daily moves in its underlying asset by a factor of two. If FIG (the underlying security) fell approximately 8.8% on this snapshot date, the 2x daily reset mechanism would amplify that into roughly the observed 17.5% loss in FIGG. The underlying decline could be driven by earnings disappointment, broader sector weakness, technical selling, or company-specific news that may not yet have appeared in the headline feed provided. Without seeing FIG's own price action or news, we cannot pinpoint the root cause, only confirm that leveraged ETFs mechanically translate underlying moves with multiplied magnitude.

BDRX

Biodexa Pharmaceuticals PlcHealthcare

$1.77−$0.36

-16.9%

NASDAQ · Mkt cap $1.4 M

BDRX fell 16.9% on a day when European equities broadly declined in US trading; no company-specific news was reported, suggesting the move reflects sector-wide or market-wide headwinds rather than Biodexa-specific developments.

The only headline provided is a generic statement that European equities traded as American Depositary Receipts tracked lower on Monday, which is a market-level observation rather than news tied to Biodexa itself. No earnings, regulatory, pipeline, or strategic announcements were disclosed in the past 48 hours. Given that BDRX is a European biotech company trading via ADR on NASDAQ, it likely participates in broad European equity weakness, but this explains only the direction, not the magnitude. For a microcap biotech stock of this type, the 16.9% drop could also reflect decreased trading liquidity, sector rotation out of smaller-cap pharma, changes in investor sentiment toward development-stage companies, or unannounced clinical or operational news not yet reflected in the RSS feeds captured.

SOXS

Direxion Daily Semiconductor Bear 3X ETF

$45.13−$8.86

-16.4%

AMEX

No news headlines were found in the last 48 hours, but SOXS is a 3X inverse semiconductor ETF, so a -16.41% decline most likely reflects a strong rally in the underlying semiconductor index that amplified losses for this bearish instrument.

The absence of any news in the provided headlines makes direct attribution impossible, but SOXS's structure offers a clear explanation pathway. SOXS is a leveraged inverse ETF designed to move -3X the daily performance of semiconductor stocks. A sharp rally in semiconductor equities—potentially driven by broader tech strength, positive earnings, sector rotation, or macro sentiment—would naturally drive this bearish ETF lower with triple leverage applied. Without specific headlines about semiconductor fundamentals or market events, we cannot pinpoint the exact catalyst, but the magnitude and direction of the move are entirely consistent with a significant upday in chip stocks that amplified inverse losses.

ERNA

Ernexa Therapeutics Inc.Healthcare

$4.54−$0.89

-16.4%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours, so the 16.4% drop in ERNA cannot be directly attributed to a specific announcement or event based on available information.

The absence of recent news makes it impossible to pinpoint a concrete catalyst for ERNA's sharp 16.4% decline on July 21, 2026. For a small-cap therapeutic company like Ernexa, typical drivers of large single-day moves include clinical trial results, regulatory decisions, partnership announcements, or shifts in guidance. Without headlines documenting any of these events, the move could reflect several possibilities: a delayed market reaction to an earlier announcement not captured in the 48-hour window, broader sector weakness in biotech, technical selling or stop-loss triggers, or unconfirmed rumors circulating in the market. The ranking as the 29th biggest loser suggests this was a material market event, but the lack of corroborating news limits confidence in any specific explanation.

SDOT

Sadot Group Inc.Consumer Defensive

$21.86−$4.28

-16.4%

NASDAQ · Mkt cap $11 M

No news headlines were published in the last 48 hours for SDOT, so the 16.37% drop cannot be directly attributed to a disclosed event. The decline likely stems from a technical or market-driven catalyst without accompanying public disclosure.

The absence of any news coverage in the last 48 hours makes it impossible to identify a specific catalyst for SDOT's sharp 16.37% decline. This gap between a significant move and silent press flow suggests several possibilities worth considering as inference only. First, the decline could be driven by technical factors such as stop-loss triggers, options expiration effects, or algorithmic selling in a lower-liquidity name. Second, SDOT may have experienced a delayed market reaction to older news that only now reached broader institutional or retail awareness. Third, the stock could be responding to sector rotation or broader market sentiment without company-specific news. Small-cap NASDAQ names like SDOT are particularly susceptible to volume-driven moves and liquidity constraints that can produce sharp single-day swings independent of fresh information. Without headline evidence, the structural context of the stock itself would be needed to narrow the hypothesis further.

CTOR

Citius Oncology, Inc.Healthcare

$0.57+$0.00

-16.2%

NASDAQ · Mkt cap $80 M

Citius Oncology announced expansion of its LYMPHIR commercial organization and increasing market adoption on the day of the decline, but the headline does not explain why the stock fell 16.16%, suggesting the market may have reacted negatively to details in the full release or broader sector head…

The headline released on 2026-07-21 announces nationwide deployment of LYMPHIR's broadened commercial organization and expanding market adoption, which typically would be viewed as a positive development for an oncology biotech company. However, the stock declined sharply the same day it was announced, which is counterintuitive. The RSS headline excerpt is incomplete and does not contain the full press release details, so material information explaining investor disappointment could be hidden in the unshown body of the announcement—such as lower-than-expected adoption rates, margin guidance, commercial spending guidance, or product sales data. Alternatively, the decline may reflect broader sector rotation, profit-taking, or a delayed market reaction to prior news unrelated to this announcement.

BHST

BioHarvest Sciences Inc. Common StockConsumer Defensive

$2.28−$0.43

-15.9%

NASDAQ · Mkt cap $46 M

BioHarvest Sciences fell 15.87% on a major down day with no news headlines available in the last 48 hours, suggesting the move was driven by sector weakness, technical selling, or an undisclosed catalyst not yet reflected in headlines.

No news headlines were found in the 48-hour window preceding this 15.87% decline, which rules out a company-specific announcement as the identifiable cause. BioHarvest is a small-cap biotech firm, a sector category prone to volatility driven by sentiment shifts, hedge fund positioning, short covering reversals, or broad risk-off trading in growth stocks. The magnitude of the drop and the ranking as the 32nd biggest loser suggests either concentrated selling pressure in the stock itself or participation in a broader biotech sector decline. Without access to intraday news, regulatory filings, or social media catalysts, the specific trigger remains opaque. Possibilities include delayed disclosure of clinical trial results, insider selling, funding concerns, or rotation out of unprofitable life sciences names during a market correction, but these are hypothetical categories rather than confirmed facts.

ATHR

Aether Holdings, Inc. Common StockTechnology

$3.94−$0.74

-15.8%

NASDAQ · Mkt cap $47 M

Aether Holdings announced a major strategic pivot into AI modular data center infrastructure through partnerships with Virtual Grid on July 20, but the market sold off 15.81% the following day, suggesting investor skepticism about execution, valuation, or market timing despite the headline being …

On July 20, Aether announced two related developments: the launch of Aether Compute as a new business line focused on modular data center infrastructure, and a strategic partnership with Virtual Grid granting Aether exclusive Southeast Asia rights and non-exclusive U.S. rights to commercialize AetherPod technology. Nominally these are growth announcements, yet the stock dropped sharply on July 21. This disconnect suggests the market is either concerned about the capital requirements and execution risk of entering a competitive AI infrastructure space, skeptical of the partnership terms or Virtual Grid's technology, worried about dilution from the investment, or questioning whether this is the right strategic direction for the company. The timing in mid-2026 during a potential AI cycle trough could also factor into valuation concerns. Without earnings context, insider commentary, or analyst reaction, the precise driver remains unclear.

GDXD

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

$49.81−$9.11

-15.5%

AMEX

No news headlines were found in the last 48 hours, but GDXD is a -3X inverse leveraged ETN on gold miners, so the 15.46% drop likely reflects a sharp rise in the underlying gold mining sector or gold prices, which would cause this inverse product to decline sharply.

GDXD is structured as a negative three-times leveraged product tracking gold miners, meaning it gains when gold miners fall and loses when they rise. Without any news headlines identified in the provided data, the 15.46% loss most likely stems from a significant rally in either gold prices, gold mining equities, or both. Given the leveraged structure, even a moderate 5-6% move upward in the underlying index would produce the observed decline. The absence of company-specific or sector news in the Yahoo Finance RSS feed suggests the move was driven by broad commodity market action or macroeconomic factors affecting precious metals rather than a discrete newsworthy event. Gold mining equities tend to be sensitive to real interest rates, USD strength, inflation expectations, and geopolitical risk, any of which could have shifted positively for miners over the prior session.

LKSPR

Lake Superior Acquisition Corp. – Rights

$0.93−$0.17

-15.4%

NASDAQ

No news emerged in the last 48 hours to explain the 15.45% decline in LKSPR rights. The drop likely reflects typical illiquidity and volatility in SPAC warrant or rights markets, or a broader sector pullback.

Lake Superior Acquisition Corp. is a SPAC, and LKSPR represents rights associated with that vehicle. SPAC rights and warrants are inherently volatile and illiquid instruments that can swing sharply on minimal volume or technical factors, independent of company-specific news. Without headlines available, the decline cannot be anchored to a specific catalyst such as a merger termination, deal announcement, or deadline event. Possible explanations include profit-taking after a prior rally, a broader decline in blank-check equity sentiment, or simply thin trading amplifying a small shift in demand. Rights offerings also carry redemption or expiration mechanics that can drive sharp moves on calendar-based expectations rather than news flow.

HCICR

Hennessy Capital Investment Corp. VIII Share Rights

$0.16−$0.03

-15.3%

NASDAQ

No news headlines were published in the last 48 hours, so the 15.26% decline cannot be attributed to any identifiable public announcement or event. The drop may reflect typical illiquidity and volatility in a low-priced SPAC rights instrument.

No recent news was available to explain the price movement. HCICR is a share rights instrument tied to a SPAC (special purpose acquisition company), a security class characterized by extremely low trading volume and wide bid-ask spreads. Rights offerings trade infrequently and with minimal liquidity, making price movements on days with no news common and often driven by technical factors, small order flows, or delayed reactions to older news rather than new fundamental catalysts. Without headlines or identified structural events, the decline could reflect routine illiquidity, a small seller pushing the bid lower, or market participants reassessing the value of the underlying SPAC position, but these remain speculative inferences rather than established causes.

Horizon Quantum Holdings Ltd. Class A Ordinary SharesTechnology

$16.69−$2.91

-14.8%

NASDAQ · Mkt cap $905 M

Horizon Quantum announced its Q2 earnings release date for August 4, 2026, but no financial results or guidance were disclosed today, making it unlikely this announcement alone triggered a 14.85% drop. The decline likely reflects broader market sentiment, sector weakness, or undisclosed news not …

The only headline available is a routine announcement that Horizon Quantum will report Q2 results on August 4. This is standard corporate disclosure and does not contain any surprising financial data, guidance changes, contract wins, losses, or operational updates that would typically explain a sharp single-day decline. Quantum computing stocks have been volatile and subject to sentiment shifts around technology cycles and funding environments. The 14.85% drop on the day of an earnings announcement notice suggests either a concurrent negative catalyst not reflected in the provided headlines, a sector-wide selloff in quantum or software infrastructure stocks, or market speculation ahead of the August 4 results. Without access to broader market context or additional news, the true cause remains unclear.

STAK

STAK Inc. Ordinary SharesEnergy

$1.44−$0.24

-14.3%

NASDAQ · Mkt cap $29 M

No news was reported on STAK in the last 48 hours, so the 14.29% drop likely reflects a technical pullback, sector rotation, or unannounced corporate development that has not yet surfaced in public headlines.

The absence of any headline coverage in the last 48 hours makes it impossible to pinpoint a specific catalyst for the sharp single-day decline. For a micro-cap or lower-liquidity stock trading at $1.44, price moves of this magnitude can result from several sources: a delayed earnings report or guidance revision that has not yet reached news aggregators, technical selling following a prior rally, rotation out of speculative positions, insider transactions, or an industry-wide downturn in its sector. Without knowing STAK's business model, recent performance, or market conditions in its peer group, attributing the move to any particular category would be speculative. The magnitude of the drop suggests something more material than random intraday noise, but without evidence it remains unclear whether the driver is company-specific, sector-wide, or technical in nature.

RGTZ

Daily Target 2X Short RGTZ ETF

$5.23−$0.86

-14.1%

NASDAQ

No news headlines were found in the last 48 hours, but RGTZ is a 2X inverse leveraged ETF, so a sharp 14% drop likely reflects a corresponding surge in its underlying asset or benchmark on strong market momentum.

The absence of any news in the provided headlines makes it impossible to pinpoint a specific catalyst for RGTZ's decline. However, RGTZ is structured as a daily 2X short ETF, meaning it moves inversely to its underlying index or stock with 2X leverage. A 14% drop in this security would typically correspond to a roughly 7% rally in the underlying asset. This kind of move could be driven by broad market strength, a sector rally, positive earnings surprises, Fed policy shifts, or macroeconomic data beating expectations. Without knowing the underlying asset or accessing real-time market data, the most probable cause is either a strong equity market day or specific positive news affecting the underlying that was not captured in the Yahoo Finance headlines provided.

GOAI

Eva Live, Inc.Technology

$2.03−$0.33

-14.0%

NASDAQ · Mkt cap $69 M

Eva Live announced an acquisition of Airbeam Wireless Technologies on July 20th, and the stock fell 14% the next day, suggesting investor skepticism about deal terms, financing concerns, or dilution fears despite the company's framing of a $3 trillion market opportunity.

Eva Live released two announcements on July 20th detailing a letter of intent to acquire a 51% controlling stake in Airbeam Wireless, with an option for the remaining 49%. The company emphasized Airbeam's 260+ patents, advanced millimeter-wave semiconductor technology, and access to a stated $3 trillion global defense, satellite and AI infrastructure opportunity. However, the headlines provide no details on acquisition price, funding mechanism, dilution to existing shareholders, or earn-out structures. The 14% decline on July 21st suggests the market reacted negatively despite the strategic framing. Possible explanations include concerns about valuation, uncertainty over how the deal will be financed (debt or equity issuance), skepticism about the claimed $3 trillion market size, or general caution toward speculative acquisition announcements from micro-cap stocks. The lack of specific financial terms in the available headlines makes it difficult to identify the precise source of the sell-off.

CLDI

Calidi Biotherapeutics, Inc.Healthcare

$0.10−$0.02

-13.9%

AMEX · Mkt cap $3.4 M

Calidi announced a 1-for-16 reverse stock split effective July 31, which typically signals financial distress and dilution concerns, likely outweighing positive FDA pre-IND feedback announced the same day for its CLD-401 program.

Calidi released two major announcements within 24 hours. On July 21, the company disclosed positive pre-IND feedback from the FDA for CLD-401 with a Q1 2027 dosing target, which is ordinarily positive for a biotech stock. However, on July 20, the company announced a 1-for-16 reverse stock split effective July 31, a structural event that typically reflects severe cash constraints, dilution concerns, or attempts to regain compliance with exchange listing standards. Reverse splits are generally viewed negatively by markets because they often precede capital raises or signal operational distress. The timing—announcing good news the day after the reverse split announcement—suggests the market may have already priced in significant negative sentiment regarding the company's financial position, and the FDA news was insufficient to overcome that headwind. For a micro-cap biotech at $0.10 pre-split, the reverse split combined with the stock's rank as the 41st biggest loser suggests the market is focused on dilution risk and balance sheet concerns rather than near-term clinical progress.

SKYQ

Sky Quarry Inc.Energy

$4.08−$0.66

-13.9%

NASDAQ · Mkt cap $12 M

Sky Quarry fell 13.92% today likely due to negative sentiment around Western refinery capacity decline, which could threaten demand for its Nevada refining operations if the broader trend accelerates.

The single headline provided discusses declining refinery capacity across the Western United States and mentions that one Nasdaq company operates the only refinery in Nevada. While the headline does not name Sky Quarry directly or provide specific negative news about the company, the context suggests structural headwinds for Western refining capacity. The timing of the headline publication (2026-07-21 13:05) matches the trading day, making it a plausible catalyst. However, the headline's framing is ambiguous—it could be highlighting a scarcity advantage for the Nevada operator, or it could be reflecting broader industry weakness. Without additional detail on what the article actually concludes about margins, demand, or regulatory pressure, the causal link remains inference rather than confirmed fact. The 13.92% drop suggests material concern among investors, but the evidence provided does not establish whether this is company-specific or sector-driven pessimism.

SMCZ

Daily Target 2X Short SMCI ETF

$11.01−$1.78

-13.9%

NASDAQ

No news headlines available in the last 48 hours, but SMCZ is a 2X leveraged short ETF tracking Super Micro Computer (SMCI), so a 13.92% drop likely reflects a sharp rally in SMCI stock itself.

SMCZ is a daily inverse leverage product that moves approximately negative two times the daily return of SMCI. With no news provided about SMCI or SMCZ in the past 48 hours, the 13.92% decline in SMCZ most probably stems from SMCI rallying significantly. Given SMCI's history as a volatile semiconductor and server manufacturer stock subject to supply chain news, earnings revisions, data center demand shifts, and short-squeeze activity, any positive catalyst affecting SMCI directly—whether an earnings beat, positive guidance, large customer orders, or short covering—would automatically generate an outsized negative move in this inverse leveraged ETF. Without specific headlines about SMCI itself, the most likely categories are positive semiconductor or AI infrastructure developments, or technical mean-reversion after prior weakness.

JEM

707 Cayman Holdings Limited Ordinary SharesConsumer Cyclical

$3.72−$0.60

-13.9%

NASDAQ · Mkt cap $2.8 M

JEM fell 13.89% on July 21 with no news headlines found in the prior 48 hours, suggesting the decline was driven by technical selling, market-wide pressure, or unreported company-specific developments.

The absence of any identifiable news headline in the last 48 hours makes it difficult to pinpoint a specific catalyst for the 13.89% single-day drop. JEM is a Cayman Islands holding company traded on NASDAQ, a relatively illiquid security that can be sensitive to redemptions, insider moves, or shifts in investor sentiment toward offshore structures. Without access to company filings, insider transactions, or real-time market commentary, the most likely causes fall into a few categories: broad market weakness affecting smaller-cap equities, a significant redemption or capital event at the holding company level, technical selling after a prior run-up, or an announcement made during market hours that did not immediately propagate to the news feeds checked. Holding companies and offshore structures sometimes experience sharp moves on thin volume with minimal media coverage.

VBIO

Valion Bio, Inc.Healthcare

$0.31−$0.05

-13.9%

NASDAQ · Mkt cap $559 K

Valion Bio fell 13.87% despite announcing a positive clinical milestone with Sheba Medical Center selecting Entolimod for a neutropenia trial; the disconnect between good news and the price drop suggests either market skepticism about commercial viability or an unrelated negative catalyst.

The headline from July 20 describes what appears to be a favorable clinical development: a world-leading cancer center has selected Valion Bio's Entolimod for a trial to address the multi-billion-dollar neutropenia market. Ordinarily, such news would support stock appreciation or at minimum neutrality. The 13.87% decline despite this announcement is counterintuitive and suggests either that investors view the development as insufficiently de-risking or that an unstated negative catalyst drove the move. For micro-cap biotech stocks trading below one dollar, moves of this magnitude often reflect shallow liquidity, short covering reversals, or reactions to clinical trial details not captured in the headline summary. Without additional reporting on trial design concerns, competitive threats, financing developments, or management changes, the precise cause remains opaque.

DUOG

Leverage Shares 2x Long DUOL Daily ETF

$44.32−$7.08

-13.8%

NASDAQ

No headlines were published in the last 48 hours, but the 13.78% drop in this 2x leveraged long ETF most likely reflects a sharp decline in its underlying asset DUOL, amplified by the fund's 2x daily leverage structure.

DUOG is a 2x daily leveraged ETF tracking DUOL, meaning it is designed to deliver twice the daily return of its underlying index or security. With no news headlines available to explain a market event, the most probable cause of the 13.78% drop is a significant decline in DUOL itself, which would have experienced roughly a 6.9% loss and then been amplified by the 2x leverage factor. Leveraged ETFs are sensitive to both market-wide volatility and underlying asset weakness. Without headline evidence, the catalyst could fall into several categories: sector or market rotation affecting DUOL, deterioration in its composition or credit quality, or broad market downward pressure on that specific asset class. The absence of news does not rule out a non-public catalyst, delayed disclosure, or technical selling.

ADGM

Adagio Medical Holdings, Inc.Healthcare

$0.44−$0.07

-13.4%

NASDAQ · Mkt cap $14 M

No news headlines were available in the last 48 hours, so the 13.38% decline on ADGM cannot be directly attributed to a specific announcement or event based on the evidence provided.

The absence of recent news headlines makes it impossible to identify a definitive catalyst for the sharp 13.38% single-day drop in ADGM stock. For a small-cap biomedical or medical device company like Adagio Medical, typical drivers of significant daily moves include clinical trial results, regulatory decisions, analyst downgrades, insider selling, partnership announcements, or guidance revisions. Without access to news, the decline could reflect delayed market reaction to older information, technical selling pressure in a low-liquidity stock, sector rotation away from healthcare equities, or company-specific rumors not yet captured in major news feeds. The stock's position as the 47th biggest loser suggests broad participation in the move rather than a purely technical or thin-volume event.

PAPL

Pineapple Financial Inc.Financial Services

$0.76−$0.12

-13.4%

AMEX · Mkt cap $25 M

Pineapple Financial reported strong Q3 earnings and asset growth on July 20, but the stock fell 13.37% the next day, suggesting the market either disappointed on forward guidance, missed profit expectations relative to consensus, or reacted to sector headwinds unrelated to the headline figures.

The news released July 20 highlights positive metrics: $25.3 million net income, $51.6 million shareholders' equity, $75.9 million total assets, and 11.6% subscription revenue growth year-to-date, plus $621,000 from a Digital Asset Treasury strategy. These appear constructive on their surface. However, the magnitude of the one-day decline (48th biggest loser) suggests either the earnings fell short of street expectations despite the absolute numbers being positive, management provided cautious forward guidance, or the market focused on metrics not mentioned in the truncated headline. Alternatively, the drop could reflect sector-wide selling in fintech or digital asset-adjacent stocks unrelated to company-specific news. Without full earnings transcript details or analyst consensus figures, the exact trigger remains unclear.

CHAI

Core AI Holdings IncCommunication Services

$0.39−$0.06

-13.2%

NASDAQ · Mkt cap $6.8 M

CHAI fell 13.22% despite announcing HomeGPT, an AI-powered residential decision platform, suggesting the market either viewed the news as insufficient or broader negative sentiment overwhelmed the positive announcement.

The only headline provided is a press release from July 21 announcing HomeGPT expansion into multimodal home design and AI-powered residential decision tools as part of Core AI's vertical AI strategy. This is nominally positive news, yet the stock dropped 13.22% on the same day. This disconnect suggests either the market had already priced in expectations for such announcements and found the execution disappointing, or the decline was driven by factors unrelated to the HomeGPT news, such as broader market weakness in AI stocks, short-seller activity, or macroeconomic concerns affecting smaller-cap tech names. Without additional context on CHAI's recent valuation, insider selling, or competing announcements that same day, we cannot definitively link the decline to the HomeGPT release itself.

MKLYR

McKinley Acquisition Corporation Rights

$0.20−$0.03

-13.0%

NASDAQ

No news headlines were available in the last 48 hours, so the 13% decline in MKLYR rights cannot be directly attributed to a specific announced event; the move likely reflects typical volatility in blank-check company equity or rights offerings.

McKinley Acquisition Corporation Rights are a derivative security tied to a special purpose acquisition company structure. The absence of any news in the last 48 hours means we cannot point to an earnings miss, deal announcement, regulatory action, or guidance change as the cause. Rights in SPAC offerings are inherently volatile instruments with low trading volume and wide spreads, making them susceptible to momentum-driven selling, sector rotation away from blank-check vehicles, or redemption pressure tied to parent company uncertainty. The ranking as the 50th biggest loser suggests broad-market weakness in small-cap equity derivatives rather than company-specific catastrophe, but without headlines or volume data we cannot confirm the mechanism.